197 related articles for article (PubMed ID: 21423645)
1. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania.
Cajas-Monson LC; Mkocha H; Muñoz B; Quinn TC; Gaydos CA; West SK
PLoS Negl Trop Dis; 2011 Mar; 5(3):e978. PubMed ID: 21423645
[TBL] [Abstract][Full Text] [Related]
2. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
[TBL] [Abstract][Full Text] [Related]
3. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
West SK; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Foster A; Bailey RL; Mabey DC
Lancet; 2005 Oct; 366(9493):1296-300. PubMed ID: 16214600
[TBL] [Abstract][Full Text] [Related]
4. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
[TBL] [Abstract][Full Text] [Related]
5. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
[TBL] [Abstract][Full Text] [Related]
6. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
[TBL] [Abstract][Full Text] [Related]
7. Mass treatment with single-dose azithromycin for trachoma.
Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
[TBL] [Abstract][Full Text] [Related]
8. Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment.
Yohannan J; He B; Wang J; Greene G; Schein Y; Mkocha H; Munoz B; Quinn TC; Gaydos C; West SK
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4144-50. PubMed ID: 24906862
[TBL] [Abstract][Full Text] [Related]
9. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
Ramadhani AM; Derrick T; Macleod D; Massae P; Malisa A; Mbuya K; Mtuy T; Makupa W; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007559. PubMed ID: 31306419
[TBL] [Abstract][Full Text] [Related]
10. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.
Campbell JP; Mkocha H; Munoz B; West SK
Ophthalmic Epidemiol; 2012 Feb; 19(1):38-42. PubMed ID: 22273357
[TBL] [Abstract][Full Text] [Related]
11. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
12. Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.
Gower EW; Solomon AW; Burton MJ; Aguirre A; Muñoz B; Bailey R; Holland M; Makalo P; Massae P; Mkocha H; Mabey DC; West SK
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4767-71. PubMed ID: 17065486
[TBL] [Abstract][Full Text] [Related]
13. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
Burton MJ; Holland MJ; Makalo P; Aryee EA; Sillah A; Cohuet S; Natividad A; Alexander ND; Mabey DC; Bailey RL
PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957147
[TBL] [Abstract][Full Text] [Related]
14. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
[TBL] [Abstract][Full Text] [Related]
15. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
[TBL] [Abstract][Full Text] [Related]
17. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
Yohannan J; Munoz B; Mkocha H; Gaydos CA; Bailey R; Lietman TA; Quinn T; West SK
JAMA Ophthalmol; 2013 Apr; 131(4):431-6. PubMed ID: 23392481
[TBL] [Abstract][Full Text] [Related]
18. Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma?
West SK; Stare D; Mkocha H; Munoz B; Gaydos C; Quinn TC
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):6040-2. PubMed ID: 21680866
[TBL] [Abstract][Full Text] [Related]
19. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.
Broman AT; Shum K; Munoz B; Duncan DD; West SK
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):99-104. PubMed ID: 16384950
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of high dose azithromycin compared to standard dosing for children with severe trachoma in Tanzania.
Campbell JP; Mkocha H; Munoz B; West SK
Ophthalmic Epidemiol; 2009; 16(3):175-80. PubMed ID: 19437312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
